Mohamad Makhzoumi

General Partner, Menlo Park

Photo of Mohamad Makhzoumi

Mohamad Makhzoumi is a General Partner and Head of NEA’s Global Healthcare Investing practice, which typically accounts for $1.5 billion of investments every two to three years across healthcare services, healthcare IT, biopharma and medical devices. Mohamad’s personal investment practice is primarily focused on the healthcare services and healthcare information technology sectors where he is currently a Director of Aetion, American Pathology Partners, Bright Health, Collective Health, Curisium, Nuvolo, Paladina Health, Radiology Partners, SCI Solutions, Strive Health, and Welltok. Mohamad’s past investments include Bravo Health, CHG Healthcare, DaVita NephroLife, DSI Renal, Golden State Medical Supply, Long Term Care Group, ppoNEXT, U.S. Renal Care, and Vantage Oncology.

Previously, Mohamad focused on growth equity investments at Summit Partners prior to which he worked with UBS Investment Bank where he concentrated on leveraged finance and sponsor-led transactions. Mohamad received a bachelor's degree, with distinction, from the University of Pennsylvania and is a board member of The National Venture Capital Association (NVCA).

Experience

  • NEA
    2000–2001 NEA
  • UBS
    2001–2003 UBS Investment Bank
  • Summit Partners
    2003–2005 Summit Partners
  • NEA
    2005–present NEA

Companies